Tag: Phase I
Cynata’s CYP-001 Stem Cell Therapy Meets Expectations In Phase 1 Graft-Versus-Host Disease Trial
Cynata Therapeutics Limited is an Australian clinical-stage stem cell and regenerative medicine company founded in 2003 that is developing a therapeutic stem cell platform technology, Cymerus™, originating from the University of Wisconsin-Madison, a world leader in stem cell research..
CYP-001,...
